Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities.

Authors

Swati Antala, Jennifer Halma, Irini Batsis, Sarah Maxwell, Vikram Raghu, Vicky Ng, Steven Lobritto, Daniel H Leung, Regino P Gonzalez-Peralta, Simon P Horslen, George Mazariegos, John C Bucuvalas, Catherine Chapin, Frank DiPaola, Noelle Ebel, Juliet Emamaullee, Kambi Etezami, Amy G Feldman, Nitika Gupta, Evelyn Hsu, Anna L Peters, Rene Romero, Pamela Valentino, Robert S Venick, James E Squires, Emily R Perito

Published in

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. Jun 22, 2026. Epub Jun 22, 2026.

Abstract

Post-transplant immunosuppression (IS) significantly impacts patient and graft outcomes. The Starzl Network for Excellence in Pediatric Transplantation (SNEPT), a multicenter learning health network dedicated to pediatric liver transplant, identified IS optimization as a priority project. Here we describe SNEPT's development of consensus care plans (CCPs) for induction IS after pediatric liver transplantation, using an adapted nominal group technique to achieve consensus. First, 16 SNEPT transplant centers across the U.S. and Canada shared individual center IS protocols. Collation of center-specific protocols identified five key medications (basiliximab, thymoglobulin, corticosteroids, mycophenolate mofetil, and tacrolimus). Dosing consensus and variability across all 16 center protocols were summarized by SNEPT's Optimizing IS working group. Through iterative cycles of feedback conducted in-person and virtually, 2022-2025, CCPs for each medication were developed, reviewed with stakeholders and revised. CCPs were finalized with consensus from all 16 centers. CCPs were presented at SNEPT's network-wide meeting as well as at individual center multidisciplinary meetings to assess accuracy of captured current practice and agreement with implementation. CCPs were finalized with universal network consensus and will be implemented across the network, laying foundational work for prospective quality improvement and comparative effectiveness studies.

PMID:
42329107
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.